Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1977-4-30
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-8504
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
109-12
|
pubmed:dateRevised |
2008-2-12
|
pubmed:meshHeading |
pubmed-meshheading:65852-Antibody Formation,
pubmed-meshheading:65852-Carcinoembryonic Antigen,
pubmed-meshheading:65852-Chronic Disease,
pubmed-meshheading:65852-Colitis, Ulcerative,
pubmed-meshheading:65852-Crohn Disease,
pubmed-meshheading:65852-Humans,
pubmed-meshheading:65852-Proctitis,
pubmed-meshheading:65852-Smoking
|
pubmed:year |
1976
|
pubmed:articleTitle |
[Clinical value of the plasma-CEA-concentrations for the activity control of chronic inflammatory intestinal diseases].
|
pubmed:publicationType |
Journal Article
|